Literature DB >> 28484151

Surgical Treatment for Pulmonary Metastasis of Head and Neck Cancer: Study of 58 Cases.

Yuki Nakajima1, Yoshihito Iijima1, Hiroyasu Kinoshita1, Hirohiko Akiyama1, Takeshi Beppu2, Hidetaka Uramoto1,3, Tomomi Hirata1.   

Abstract

PURPOSE: Although the number of surgeries performed for pulmonary metastasis of head and neck cancer has been increasing, there have been few reports of the surgical effectiveness. We collected the data of surgeries performed in our facility in order to discuss the surgical performance and indication.
METHODS: We retrospectively examined the prognosis and predictors for 58 patients with pulmonary metastasis of head and neck cancer who underwent a surgery in our facility during the 15-year period, from January 2000 to December 2015.
RESULTS: The 3-year and 5-year survival rates were 54.2% and 35.7%, respectively, and the median survival time was 42.2 months. The disease-free interval (DFI) was less than 24 months and patients with oral cavity cancer were poor prognostic factors.
CONCLUSION: The effectiveness of surgical treatment for pulmonary metastasis of head and neck cancer was suggested.

Entities:  

Keywords:  head and neck cancer; metastasectomy; oral cavity cancer; pulmonary metastasis; surgical indication

Mesh:

Year:  2017        PMID: 28484151      PMCID: PMC5569250          DOI: 10.5761/atcs.oa.16-00269

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  14 in total

1.  THE SURGICAL TREATMENT OF METASTATIC TUMORS IN THE LUNGS.

Authors:  N R THOMFORD; L B WOOLNER; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1965-03       Impact factor: 5.209

2.  Pulmonary metastasectomy for head and neck cancers.

Authors:  D Liu; D M Labow; N Dang; N Martini; M Bains; M Burt; R Downey; V Rusch; J Shah; R J Ginsberg
Journal:  Ann Surg Oncol       Date:  1999-09       Impact factor: 5.344

3.  Surgical treatment for pulmonary metastases of squamous cell carcinoma of the head and neck.

Authors:  K Nibu; K Nakagawa; S Kamata; K Kawabata; M Nakamizo; T Nigauri; K Hoki
Journal:  Am J Otolaryngol       Date:  1997 Nov-Dec       Impact factor: 1.808

4.  How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations?

Authors:  Akito Hata; Nobuyuki Katakami; Hiroshige Yoshioka; Kei Kunimasa; Shiro Fujita; Reiko Kaji; Kenji Notohara; Yukihiro Imai; Ryo Tachikawa; Keisuke Tomii; Yohei Korogi; Masahiro Iwasaku; Akihiro Nishiyama; Tadashi Ishida
Journal:  J Thorac Oncol       Date:  2013-01       Impact factor: 15.609

5.  Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas.

Authors:  Satoshi Shiono; Masafumi Kawamura; Toru Sato; Sakae Okumura; Jun Nakajima; Ichiro Yoshino; Norihiko Ikeda; Hirotoshi Horio; Hirohiko Akiyama; Koichi Kobayashi
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

6.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

7.  Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck.

Authors:  R K Finley; G T Verazin; D L Driscoll; L E Blumenson; H Takita; V Bakamjian; K Sako; W Hicks; N J Petrelli; D P Shedd
Journal:  Am J Surg       Date:  1992-12       Impact factor: 2.565

8.  Does surgical resection of pulmonary metastases of head and neck cancer improve survival?

Authors:  Hauke Winter; Georgios Meimarakis; Gabriele Hoffmann; Manuela Hummel; Dominik Rüttinger; Astrid Zilbauer; Klaus Stelter; Fritz Spelsberg; Karl-Walter Jauch; Rudolph Hatz; Florian Löhe
Journal:  Ann Surg Oncol       Date:  2008-07-22       Impact factor: 5.344

9.  Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.

Authors:  Hyun Woo Jeon; Young-Du Kim; Kyung Soo Kim; Sook Whan Sung; Hyung Joo Park; Jae Kil Park
Journal:  World J Surg Oncol       Date:  2014-07-16       Impact factor: 2.754

10.  Thoracic and cardiovascular surgery in Japan during 2013: Annual report by The Japanese Association for Thoracic Surgery.

Authors:  Munetaka Masuda; Hiroyuki Kuwano; Meinoshin Okumura; Hirokuni Arai; Shunsuke Endo; Yuichiro Doki; Junjiro Kobayashi; Noboru Motomura; Hiroshi Nishida; Yoshikatsu Saiki; Fumihiro Tanaka; Kazuo Tanemoto; Yasushi Toh; Hiroyasu Yokomise
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-12
View more
  3 in total

1.  Improved overall survival in head and neck cancer patients after specific therapy of distant metastases.

Authors:  Dominik Schulz; Markus Wirth; Guido Piontek; Andreas Knopf; Christoph Straube; Steffi Pigorsch; Stephanie E Combs; Anja Pickhard
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-08       Impact factor: 2.503

2.  Pulmonary metastasis of head and neck cancer: surgical removal outcomes from a tertiary care center.

Authors:  Abdullah AlShammari; Talal Almasri; Jumana Sarraj; Omniyah AlAshgar; Mohamed Hussein Ahmed; Khaled AlKattan; Waleed Saleh
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-10-14

3.  Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy.

Authors:  Thomas H Beckham; Jonathan E Leeman; Peng Xie; Xiaolin Li; Debra A Goldman; Zhigang Zhang; Eric Sherman; Sean McBride; Nadeem Riaz; Nancy Lee; C Jillian Tsai
Journal:  Br J Cancer       Date:  2019-10-25       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.